Subscribe to RSS Feed
Medicines-Diabetes Treatment-DHU-Ozon-Serono-PharmSintez-Nativa-Berlin-chemie-NovoNordisk-Teva-Merck Sharp & Dohme-New-pharm-Lilly-Rompharm-Elfa-OrionPharma-Belupo-Pharmstandart-KRKA-Madaus-Sintez-BelMed-ObninskPharm-Grindex-Kamelia-Lek-Adipharm-AFD-HiGlance-GeneScience Pharmaceuticals
Ozempic® (Semavik) 0,25/0,5/1 mg/dose solution for subcutaneous administration 3 ml syringe pen 1 pc.
Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.
Medicines-Diabetes Treatment-DHU-Ozon-Serono-PharmSintez-Nativa-Berlin-chemie-NovoNordisk-Teva-Merck Sharp & Dohme-New-pharm-Lilly-Rompharm-Elfa-OrionPharma-Belupo-Pharmstandart-KRKA-Madaus-Sintez-BelMed-ObninskPharm-Grindex-Kamelia-Lek-Adipharm-AFD-HiGlance-GeneScience Pharmaceuticals
Currently Shopping by
- The purpose of the medication: Remove This Item Diabetes Treatment
-
Manufacturer:
DHU
Ozon
Serono
PharmSintez
Nativa
Berlin-chemie
NovoNordisk
Teva
Merck Sharp & Dohme
New-pharm
Lilly
Rompharm
Elfa
OrionPharma
Belupo
Pharmstandart
KRKA
Madaus
Sintez
BelMed
ObninskPharm
Grindex
Kamelia
Lek
Adipharm
AFD
HiGlance
GeneScience Pharmaceuticals
- The purpose of the medication
- Manufacturer
